4.4 Article

Circulating metabolites improve the prediction of renal impairment in patients with type 2 diabetes

期刊

BMJ OPEN DIABETES RESEARCH & CARE
卷 11, 期 5, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bmjdrc-2023-003422

关键词

Diabetes Mellitus; Type 2; Kidney Diseases; Inflammation; Biomarkers

向作者/读者索取更多资源

This study investigated the association between 188 serum metabolites and kidney function in type 2 diabetes. Ten metabolites were found to be independently associated with low estimated glomerular filtration rate (eGFR), and five metabolites were associated with eGFR decline. Two of these metabolites improved clinical prediction models for GFR decline in individuals with diabetes.
Introduction Low glomerular filtration rate (GFR) is a leading cause of reduced lifespan in type 2 diabetes. Unravelling biomarkers capable to identify high-risk patients can help tackle this burden. We investigated the association between 188 serum metabolites and kidney function in type 2 diabetes and then whether the associated metabolites improve two established clinical models for predicting GFR decline in these patients. Research design and methods Two cohorts comprising 849 individuals with type 2 diabetes (discovery and validation samples) and a follow-up study of 575 patients with estimated GFR (eGFR) decline were analyzed. Results Ten metabolites were independently associated with low eGFR in the discovery sample, with nine of them being confirmed also in the validation sample (ORs range 1.3-2.4 per 1SD, p values range 1.9x10(-2)-2.5x10(-9)). Of these, five metabolites were also associated with eGFR decline (ie, tiglylcarnitine, decadienylcarnitine, total dimethylarginine, decenoylcarnitine and kynurenine) (beta range -0.11 to -0.19, p values range 4.8x10(-2) to 3.0x10(-3)). Indeed, tiglylcarnitine and kynurenine, which captured all the information of the other three markers, improved discrimination and reclassification (all p<0.01) of two clinical prediction models of GFR decline in people with diabetes. Conclusions Further studies are needed to validate our findings in larger cohorts of different clinical, environmental and genetic background.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据